AG Leiter: Assoc. Prof. PD Dr. Martin Bodingbauer
AG Leiter: Medizinische Universität Wien
Universitätsklinik für Chirurgie
Währinger Gürtel 18-20
1090 Wien
Tel: +43-1-40400-56210
Fax: +43-1-40400-56410
Email: martin.bodingbauer@meduniwien.ac.at
Stellvertreter:
OA Dr. Helwig Wundsam
helwig.wundsam@Âordensklinikum.at
Aktuelles aus der Arbeitsgruppe
Literaturhinweise
7. 01.2019- Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
- Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
- Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.
- The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly.
- The liver-first approach for locally advanced rectal cancer and synchronous liver metastases.
- A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.
- Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients – the role of the embryologic origin of the primary tumor.
- Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases.
Literaturhinweise
20. 12.2018- https://meetinglibrary.asco.org/record/160063/abstract
- https://meetinglibrary.asco.org/record/159164/abstract
- Preoperative drainage for perihilar cholangiocarcinoma – Authors‘ reply.
- Effect of Hyperbilirubinemia on Hepatic Hypertrophy after Portal Vein Embolization and Liver Failure after Heatectomy in Primary Biliary Malignancy.
- Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: a phase III STAH trial.
- Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for „Borderline Resectable“ in the Field of Surgery for Hilar Cholangiocarcinoma.
- Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma.
- Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib.
- The Short- and Long-Term Outcomes in Elderly Patients with Hepatocellular Carcinoma after Curative Surgery: A Case-Controlled Study with Propensity Score Matching.
Kongresse
12. 12.2018- The International Liver Congress, 10.-14.04.2019, Vienna, Austria
- AASLD – The Liver Meeting, 08.-12.11.2019, Boston, USA